Invention Grant
- Patent Title: CCR2 receptor antagonists and uses thereof
-
Application No.: US14260552Application Date: 2014-04-24
-
Publication No.: US09670222B2Publication Date: 2017-06-06
- Inventor: Heiner Ebel , Sara Frattini , Kai Gerlach , Riccardo Giovannini , Christoph Hoenke , Rocco Mazzaferro , Marco Santagostino , Stefan Scheuerer , Christofer Tautermann , Thomas Trieselmann
- Applicant: Centrexion Therapeutics Corporation
- Applicant Address: US MA Boston
- Assignee: Centrexion Therapeutics Corporation
- Current Assignee: Centrexion Therapeutics Corporation
- Current Assignee Address: US MA Boston
- Agency: Goodwin Procter LLP
- Priority: EP09179555 20091217; EP10162621 20100512
- Main IPC: A61K31/35
- IPC: A61K31/35 ; A61K31/445 ; A61K31/506 ; C07D405/14 ; C07D491/107
Abstract:
The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.
Public/Granted literature
- US20140235661A1 NEW CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF Public/Granted day:2014-08-21
Information query
